Continuous Glucose Monitoring (CGM) Devices Market Will Hit at A CAGR of 24.8% and To Garner US$ 27.7 Billion by 2027

Diabetes, growing at an exponential rate worldwide, has become a serious health concern globally. The disease has emerged as a major cause of death between the age group of 20 years to 80 years. Continuous research and investments are being made for effectively monitoring glucose levels which would in turn help in managing diabetes efficiently. Frequent monitoring of glucose levels is required for diabetes management so as to avoid life threatening risks such as retinopathy, heart diseases, stroke, kidney failure and others associated with hyper or hypo glycemic levels. The most extensively used glucose monitoring devices are blood glucose meters that are based on finger stick tests. However, the trend is shifting towards minimally invasive (CGM) or non-invasive glucose monitoring devices as these devices reduce the need for regular finger pricking and also lessen the pain.

The global continuous glucose monitoring (CGM) devices market was valued at US$ 3,807.3 million in 2018 and is expected to witness a robust CAGR of 24.8% over the forecast period (2019- 2027).

𝐑𝐞𝐜𝐞𝐧𝐭 𝐃𝐞𝐯𝐞𝐥𝐨𝐩𝐦𝐞𝐧𝐭𝐬

Major players operating in the global continuous glucose monitoring (CGM) devices market are focused on approval and launch of new products to expand their product portfolio. For instance, in 2016, Dexcom, Inc. received approval for Dexcom G5 Mobile CGM system from Health Canada for non-adjunctive use, thus making a new standard of care for diabetes management in Canada.

𝐁𝐮𝐲 𝐍𝐨𝐰 𝐚𝐧𝐝 𝐆𝐞𝐭 𝐅𝐥𝐚𝐭 𝐔𝐒𝐃 𝟐𝟎𝟎𝟎 𝐎𝐅𝐅

𝐏𝐮𝐫𝐜𝐡𝐚𝐬𝐞 𝐓𝐡𝐢𝐬 𝐏𝐫𝐞𝐦𝐢𝐮𝐦 𝐑𝐞𝐩𝐨𝐫𝐭 𝐓𝐨 𝐀𝐜𝐜𝐞𝐬𝐬 𝐅𝐮𝐥𝐥 𝐈𝐧𝐟𝐨𝐫𝐦𝐚𝐭𝐢𝐨𝐧 @ https://www.coherentmarketinsights.com/promo/buynow/57

𝐆𝐥𝐨𝐛𝐚𝐥 𝐂𝐨𝐧𝐭𝐢𝐧𝐮𝐨𝐮𝐬 𝐆𝐥𝐮𝐜𝐨𝐬𝐞 𝐌𝐨𝐧𝐢𝐭𝐨𝐫𝐢𝐧𝐠 (𝐂𝐆𝐌) 𝐃𝐞𝐯𝐢𝐜𝐞𝐬 𝐌𝐚𝐫𝐤𝐞𝐭: 𝐃𝐫𝐢𝐯𝐞𝐫𝐬

The global continuous glucose monitoring (CGM) devices market growth is driven by high prevalence of diabetes. For instance, according to the study, ‘Global Prevalence of Type 2 Diabetes over the Next Ten Years (2018-2028)’, published by the American Diabetes Association, 500 million people worldwide suffered from type 2 diabetes in 2018.

𝐌𝐚𝐫𝐤𝐞𝐭 𝐓𝐫𝐞𝐧𝐝𝐬:

North America is expected to witness significant growth in the global continuous glucose monitoring (CGM) devices market, owing to high prevalence of diabetes in the region. For instance, according to International Diabetes Federation’s IDF Diabetes Atlas 2019 Edition, the numbers of adults with diabetes in the U.S. was 31.0 million.

Asia Pacific is also expected to witness significant growth in the global continuous glucose monitoring (CGM) devices market, owing to funding for adoption of CGM devices. For instance, in 2017, National Diabetes Services Scheme by the Government of Australia offered fully subsidized CGM products to eligible children and young people aged under 21 years with type 1 diabetes.

𝐓𝐨 𝐆𝐞𝐭 𝐒𝐚𝐦𝐩𝐥𝐞 𝐑𝐞𝐩𝐨𝐫𝐭 𝐰𝐢𝐭𝐡 𝐋𝐚𝐭𝐞𝐬𝐭 𝐂𝐨𝐯𝐢𝐝𝟏𝟗 𝐈𝐦𝐩𝐚𝐜𝐭 𝐀𝐧𝐚𝐥𝐲𝐬𝐢𝐬 @ https://www.coherentmarketinsights.com/insight/request-sample/57

𝐆𝐥𝐨𝐛𝐚𝐥 𝐂𝐨𝐧𝐭𝐢𝐧𝐮𝐨𝐮𝐬 𝐆𝐥𝐮𝐜𝐨𝐬𝐞 𝐌𝐨𝐧𝐢𝐭𝐨𝐫𝐢𝐧𝐠 (𝐂𝐆𝐌) 𝐃𝐞𝐯𝐢𝐜𝐞𝐬 𝐌𝐚𝐫𝐤𝐞𝐭: 𝐑𝐞𝐬𝐭𝐫𝐚𝐢𝐧𝐭𝐬

Need for periodic calibration of the device is a major issue that may hinder the uptake of CGM devices. Most of the CGM systems currently available are based on minimally invasive approach that utilizes sensors to measure the glucose concentration level in the interstitial fluid. The sensors present in the device need to be changed periodically as they are prone to biofouling, which might lead to inaccurate readings. Hence, majority of the commercially available CGM devices are currently not used for making therapeutic decisions as the readings provided by the device might be inaccurate. In order to overcome this, finger stick testing is required on a daily basis for its calibration.

𝐆𝐥𝐨𝐛𝐚𝐥 𝐂𝐨𝐧𝐭𝐢𝐧𝐮𝐨𝐮𝐬 𝐆𝐥𝐮𝐜𝐨𝐬𝐞 𝐌𝐨𝐧𝐢𝐭𝐨𝐫𝐢𝐧𝐠 (𝐂𝐆𝐌) 𝐃𝐞𝐯𝐢𝐜𝐞𝐬 𝐌𝐚𝐫𝐤𝐞𝐭: 𝐂𝐨𝐦𝐩𝐞𝐭𝐢𝐭𝐢𝐯𝐞 𝐋𝐚𝐧𝐝𝐬𝐜𝐚𝐩𝐞

Major players operating in the global continuous glucose monitoring (CGM) devices market include, 𝗔𝗯𝗯𝗼𝘁𝘁 𝗟𝗮𝗯𝗼𝗿𝗮𝘁𝗼𝗿𝗶𝗲𝘀, 𝗗𝗲𝘅𝗰𝗼𝗺, 𝗜𝗻𝗰., 𝗚𝗘 𝗛𝗲𝗮𝗹𝘁𝗵𝗰𝗮𝗿𝗲, 𝗚𝗹𝘆𝗰𝗲𝗻𝘀, 𝗜𝗻𝘀𝘂𝗹𝗲𝘁 𝗖𝗼𝗿𝗽𝗼𝗿𝗮𝘁𝗶𝗼𝗻, 𝗠𝗲𝗱𝘁𝗿𝗼𝗻𝗶𝗰, 𝗽𝗹𝗰, 𝗠𝗲𝗱𝘁𝗿𝘂𝗺 𝗧𝗲𝗰𝗵𝗻𝗼𝗹𝗼𝗴𝗶𝗲𝘀, 𝗜𝗻𝗰., 𝗠𝗶𝗰𝗿𝗼𝗰𝗵𝗶𝗽 𝗧𝗲𝗰𝗵𝗻𝗼𝗹𝗼𝗴𝘆 𝗜𝗻𝗰., 𝗠𝗶𝗰𝗿𝗼𝗻 𝗧𝗲𝗰𝗵𝗻𝗼𝗹𝗼𝗴𝘆 𝗜𝗻𝗰., 𝗡𝗫𝗣 𝗦𝗲𝗺𝗶𝗰𝗼𝗻𝗱𝘂𝗰𝘁𝗼𝗿𝘀, 𝗡𝗲𝗺𝗮𝘂𝗿𝗮 𝗠𝗲𝗱𝗶𝗰𝗮𝗹, 𝗜𝗻𝗰., 𝗤𝘂𝗮𝗹𝗰𝗼𝗺𝗺, 𝗦𝗲𝗻𝘀𝗲𝗼𝗻𝗶𝗰𝘀, 𝗦𝗧𝗠𝗶𝗰𝗿𝗼𝗲𝗹𝗲𝗰𝘁𝗿𝗼𝗻𝗶𝗰𝘀, 𝗧𝗮𝗻𝗱𝗲𝗺 𝗗𝗶𝗮𝗯𝗲𝘁𝗲𝘀 𝗖𝗮𝗿𝗲, 𝗧𝗮𝗶𝘄𝗮𝗻 𝗦𝗲𝗺𝗶𝗰𝗼𝗻𝗱𝘂𝗰𝘁𝗼𝗿 𝗠𝗮𝗻𝘂𝗳𝗮𝗰𝘁𝘂𝗿𝗶𝗻𝗴 𝗖𝗼𝗺𝗽𝗮𝗻𝘆 𝗟𝗶𝗺𝗶𝘁𝗲𝗱, 𝗮𝗻𝗱 𝗧𝗲𝘅𝗮𝘀 𝗜𝗻𝘀𝘁𝗿𝘂𝗺𝗲𝗻𝘁𝘀 𝗜𝗻𝗰.

𝐆𝐥𝐨𝐛𝐚𝐥 𝐂𝐨𝐧𝐭𝐢𝐧𝐮𝐨𝐮𝐬 𝐆𝐥𝐮𝐜𝐨𝐬𝐞 𝐌𝐨𝐧𝐢𝐭𝐨𝐫𝐢𝐧𝐠 (𝐂𝐆𝐌) 𝐃𝐞𝐯𝐢𝐜𝐞𝐬 𝐌𝐚𝐫𝐤𝐞𝐭: 𝐒𝐞𝐠𝐦𝐞𝐧𝐭𝐚𝐭𝐢𝐨𝐧

On the basis of component, the global continuous glucose monitoring (CGM) devices market is segmented into:

• Transmitters
• Receivers
• Insulin Pumps
• Sensors

On the basis of region, the global continuous glucose monitoring (CGM) devices market is segmented into:

• North America
• Latin America
• Europe
• Asia Pacific
• Middle East
• Africa

𝐓𝐨 𝐆𝐞𝐭 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐏𝐃𝐅 𝐁𝐫𝐨𝐜𝐡𝐮𝐫𝐞 𝐇𝐞𝐫𝐞 @ https://www.coherentmarketinsights.com/insight/request-pdf/57

Contact Us:

Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837

About US:

Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.

This release was published on openPR.